Recent Updates
Recently added Catalysts
ALT

Altimmune Announces Manufacturing Agreement with Vigene Biosciences for AdCOVID, its Single Dose Intranasal Vaccine Candidate for COVID-19

Wednesday, July 22, 2020 1 min read
Key Takeaway: Altimmune Announces Manufacturing Agreement with Vigene Biosciences for AdCOVID, its Single Dose Intranasal Vaccine Candidate for COVID-19

Full Press Release Details

Altimmune Announces Manufacturing Agreement with Vigene Biosciences for AdCOVID, its Single Dose Intranasal Vaccine Candidate for COVID-19.
Tags: ALT Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Jul 22, 2020